Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
Stopped Low accrual and loss of funding.
Conditions
- Transplant-Related Cancer
Interventions
- BIOLOGICAL: Havrix
- BIOLOGICAL: PCV13
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators